RU2008151762A - Adlh-2 ингибиторы для лечения аддикции - Google Patents
Adlh-2 ингибиторы для лечения аддикции Download PDFInfo
- Publication number
- RU2008151762A RU2008151762A RU2008151762/04A RU2008151762A RU2008151762A RU 2008151762 A RU2008151762 A RU 2008151762A RU 2008151762/04 A RU2008151762/04 A RU 2008151762/04A RU 2008151762 A RU2008151762 A RU 2008151762A RU 2008151762 A RU2008151762 A RU 2008151762A
- Authority
- RU
- Russia
- Prior art keywords
- chromen
- hydroxyphenyl
- phenyl
- methoxy
- oxadiazol
- Prior art date
Links
- 0 *c(cc1)ccc1C(C1=O)=COC2=C1I=*C(CCCC(I)=C)=*2 Chemical compound *c(cc1)ccc1C(C1=O)=COC2=C1I=*C(CCCC(I)=C)=*2 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83408306P | 2006-07-27 | 2006-07-27 | |
| US60/834,083 | 2006-07-27 | ||
| US84642806P | 2006-09-21 | 2006-09-21 | |
| US60/846,428 | 2006-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008151762A true RU2008151762A (ru) | 2010-06-27 |
Family
ID=38792141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008151762/04A RU2008151762A (ru) | 2006-07-27 | 2007-07-27 | Adlh-2 ингибиторы для лечения аддикции |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080032995A1 (und) |
| EP (1) | EP2046769A2 (und) |
| JP (1) | JP2009544742A (und) |
| KR (1) | KR20090033417A (und) |
| AU (1) | AU2007278877A1 (und) |
| CA (1) | CA2653056A1 (und) |
| CO (1) | CO6210811A2 (und) |
| EC (1) | ECSP088919A (und) |
| IL (1) | IL195400A0 (und) |
| MA (1) | MA30434B1 (und) |
| MX (1) | MX2008015765A (und) |
| NO (1) | NO20084971L (und) |
| RU (1) | RU2008151762A (und) |
| WO (1) | WO2008014497A2 (und) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080207610A1 (en) * | 2006-07-27 | 2008-08-28 | Jeff Zablocki | Aldh-2 inhibitors in the treatment of addiction |
| US8158810B2 (en) * | 2006-07-27 | 2012-04-17 | Gilead Sciences, Inc. | ALDH-2 inhibitors in the treatment of addiction |
| JO3598B1 (ar) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
| CA2679882C (en) | 2007-03-08 | 2015-12-29 | The Board Of Trustees Of The Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
| CA2682207A1 (en) | 2007-04-05 | 2008-10-16 | Cv Therapeutics, Inc. | Quinazolinone derivatives as aldh-2 inhibitors |
| RU2010122970A (ru) * | 2007-11-06 | 2011-12-20 | Си Ви Терапьютикс, Инк. (Us) | Ингибиторы aldh-2 при лечении психиатрических расстройств |
| JP2011510072A (ja) * | 2008-01-24 | 2011-03-31 | ギリアード・パロ・アルト・インコーポレイテッド | 嗜癖の処置におけるａｌｄｈ−２インヒビター |
| WO2009100380A1 (en) * | 2008-02-06 | 2009-08-13 | Cv Therapeutics, Inc. | Use of ranolazine for treating pain |
| TW201000107A (en) | 2008-04-09 | 2010-01-01 | Infinity Pharmaceuticals Inc | Inhibitors of fatty acid amide hydrolase |
| ES2477552T3 (es) | 2008-09-08 | 2014-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos |
| EP2349279A4 (en) | 2008-10-28 | 2013-12-25 | Univ Leland Stanford Junior | ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF |
| US8592007B2 (en) * | 2008-10-29 | 2013-11-26 | Merck Patent Gmbh | Liquid-crystal display |
| WO2010118159A1 (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
| WO2010118155A1 (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
| CN102834401B (zh) | 2010-02-03 | 2016-08-24 | 无限药品股份有限公司 | 脂肪酸酰胺水解酶抑制剂 |
| ES2565345T3 (es) * | 2010-02-12 | 2016-04-04 | Nivalis Therapeutics, Inc. | Nuevos inhibidores de la reductasa de s-nitrosoglutatión |
| US10457659B2 (en) | 2011-04-29 | 2019-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
| TWI567061B (zh) | 2011-07-01 | 2017-01-21 | 吉李德科學股份有限公司 | 用於治療成癮之化合物 |
| CN105358531B (zh) | 2013-03-14 | 2017-11-14 | 利兰-斯坦福大学初级学院的董事会 | 线粒体醛脱氢酶‑2调节剂和其使用方法 |
| US8933239B1 (en) | 2013-07-16 | 2015-01-13 | Dow Global Technologies Llc | Bis(aryl)acetal compounds |
| US8962779B2 (en) | 2013-07-16 | 2015-02-24 | Dow Global Technologies Llc | Method of forming polyaryl polymers |
| US9410016B2 (en) | 2013-07-16 | 2016-08-09 | Dow Global Technologies Llc | Aromatic polyacetals and articles comprising them |
| US9063420B2 (en) | 2013-07-16 | 2015-06-23 | Rohm And Haas Electronic Materials Llc | Photoresist composition, coated substrate, and method of forming electronic device |
| EP3697415A4 (en) * | 2017-10-16 | 2021-07-14 | Amygdala Neurosciences, Inc. | POLYTHERAPY FOR THE PREVENTION OF ADDICTION |
| JP7204568B2 (ja) * | 2018-04-04 | 2023-01-16 | 株式会社Cics | アミロイドβ疾患のホウ素中性子捕捉療法用化合物 |
| CN109970738B (zh) * | 2019-02-27 | 2021-07-09 | 上海工程技术大学 | 一种金雀花碱n-异黄酮类化合物及其制备方法及应用 |
| WO2023244584A1 (en) | 2022-06-14 | 2023-12-21 | Amygdala Neurosciences, Inc. | Aldh-2 inhibitor compounds and methods of use |
| US20230399299A1 (en) | 2022-06-14 | 2023-12-14 | Amygdala Neurosciences, Inc. | Aldh-2 inhibitor compounds and methods of use |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3907830A (en) * | 1970-05-27 | 1975-09-23 | Chinoin Gyogyszer Es Vegyeszet | Isoflavone derivatives |
| US4166862A (en) * | 1971-05-25 | 1979-09-04 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | Animal feed containing anabolic isoflavones |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| DE2950135A1 (de) * | 1979-12-13 | 1981-06-19 | Merck Patent Gmbh, 6100 Darmstadt | Basischer aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| JPS62201882A (ja) * | 1985-11-18 | 1987-09-05 | Yamanouchi Pharmaceut Co Ltd | イソフラボン誘導体 |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| US5204369A (en) * | 1991-07-01 | 1993-04-20 | The Endowment For Research In Human Biology | Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
| US5679806A (en) * | 1995-02-24 | 1997-10-21 | Hauser, Inc. | Process for the isolation and purification of isoflavones |
| US5783189A (en) * | 1996-04-23 | 1998-07-21 | Natural Pharmacia International, Inc. | Method for treating alcohol dependence |
| US6255497B1 (en) * | 1997-04-29 | 2001-07-03 | The Endowment For Research In Human Biology, Inc. | Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse |
| AU3899199A (en) * | 1998-05-12 | 1999-11-29 | Endowment for Research in Human Biology, Inc., The | Methods and assays useful in the treatment of alcohol dependence or alcohol abuse |
| WO2004001058A2 (en) * | 2001-05-04 | 2003-12-31 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
| CA2491089A1 (en) * | 2002-06-27 | 2004-01-08 | The Endowment For Research In Human Biology, Inc. | Compounds useful for the inhibition of aldh |
| JP2008504292A (ja) * | 2004-06-24 | 2008-02-14 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | 免疫増強用の化合物 |
| US8158810B2 (en) * | 2006-07-27 | 2012-04-17 | Gilead Sciences, Inc. | ALDH-2 inhibitors in the treatment of addiction |
| US20080207610A1 (en) * | 2006-07-27 | 2008-08-28 | Jeff Zablocki | Aldh-2 inhibitors in the treatment of addiction |
| CA2682207A1 (en) * | 2007-04-05 | 2008-10-16 | Cv Therapeutics, Inc. | Quinazolinone derivatives as aldh-2 inhibitors |
| RU2010122970A (ru) * | 2007-11-06 | 2011-12-20 | Си Ви Терапьютикс, Инк. (Us) | Ингибиторы aldh-2 при лечении психиатрических расстройств |
-
2007
- 2007-07-27 EP EP07813501A patent/EP2046769A2/en not_active Withdrawn
- 2007-07-27 RU RU2008151762/04A patent/RU2008151762A/ru unknown
- 2007-07-27 MX MX2008015765A patent/MX2008015765A/es not_active Application Discontinuation
- 2007-07-27 KR KR1020087029279A patent/KR20090033417A/ko not_active Application Discontinuation
- 2007-07-27 US US11/829,836 patent/US20080032995A1/en not_active Abandoned
- 2007-07-27 WO PCT/US2007/074665 patent/WO2008014497A2/en active Application Filing
- 2007-07-27 AU AU2007278877A patent/AU2007278877A1/en not_active Abandoned
- 2007-07-27 CA CA002653056A patent/CA2653056A1/en not_active Abandoned
- 2007-07-27 JP JP2009522029A patent/JP2009544742A/ja not_active Withdrawn
-
2008
- 2008-11-20 IL IL195400A patent/IL195400A0/en unknown
- 2008-11-26 NO NO20084971A patent/NO20084971L/no not_active Application Discontinuation
- 2008-11-27 MA MA31422A patent/MA30434B1/fr unknown
- 2008-11-28 EC EC2008008919A patent/ECSP088919A/es unknown
- 2008-12-29 CO CO08137618A patent/CO6210811A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO6210811A2 (es) | 2010-10-20 |
| CA2653056A1 (en) | 2008-01-31 |
| WO2008014497A3 (en) | 2008-04-10 |
| KR20090033417A (ko) | 2009-04-03 |
| MA30434B1 (fr) | 2009-05-04 |
| WO2008014497A2 (en) | 2008-01-31 |
| AU2007278877A1 (en) | 2008-01-31 |
| ECSP088919A (es) | 2009-01-30 |
| US20080032995A1 (en) | 2008-02-07 |
| NO20084971L (no) | 2009-02-25 |
| IL195400A0 (en) | 2009-08-03 |
| EP2046769A2 (en) | 2009-04-15 |
| JP2009544742A (ja) | 2009-12-17 |
| MX2008015765A (es) | 2009-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008151762A (ru) | Adlh-2 ингибиторы для лечения аддикции | |
| JP2009544742A5 (und) | ||
| RU2010122970A (ru) | Ингибиторы aldh-2 при лечении психиатрических расстройств | |
| RU2482112C2 (ru) | Ингибиторы киназ, применимые для лечения миелопролиферативных заболеваний и других пролиферативных заболеваний | |
| ES2660571T3 (es) | Inhibidores de la proteína tirosina fosfatasa humana y su uso farmacéutico | |
| RU2021127810A (ru) | Замещенные гетероарилом пиридины и способы применения | |
| AU2003271555B2 (en) | Use of IkappaB kinase inhibitors for the treatment of pain | |
| RU2492167C2 (ru) | Производные аминотриазола в качестве агонистов alх | |
| JP5727223B2 (ja) | オキサジアゾール・ジアリール化合物 | |
| HRP20171454T1 (hr) | Fuzionirani heterociklični spojevi kao modulatori ionskih kanala | |
| JP2019077727A (ja) | 癌の処置のための組成物 | |
| JP2015509103A (ja) | イミダゾピロリジノン化合物 | |
| JP2011501735A5 (und) | ||
| JP2015517566A (ja) | ピロロピロリジノン化合物 | |
| RU2008141511A (ru) | Конденсированные гетероциклические соединения и их применение в качестве модуляторов mglur5 | |
| JP2011510985A5 (und) | ||
| RS50340B (sr) | Supstituisani benzimidazoli | |
| HRP20181017T1 (hr) | Heterociklični spojevi i postupci uporabe | |
| JP2004531473A5 (und) | ||
| RU2008110949A (ru) | Соединения и композиции-иммуносупрессанты | |
| JP2007533732A (ja) | 線維症を処置するためのｃ−ｋｉｔ阻害剤の使用法 | |
| JP2006517572A5 (und) | ||
| RU2007132262A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
| JP2012519160A5 (und) | ||
| JP7217752B2 (ja) | Ａｃｓｓ２阻害剤およびその使用方法 |